Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Operating Leases (2019 - 2025)

Cresco Labs' Operating Leases history spans 7 years, with the latest figure at $125.7 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 7.05% year-over-year to $125.7 million; the TTM value through Dec 2025 reached $125.7 million, down 7.05%, while the annual FY2025 figure was $125.7 million, 7.05% down from the prior year.
  • Operating Leases reached $125.7 million in Q4 2025 per CRLBF's latest filing, down from $135.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $173.3 million in Q4 2022 to a low of $118.9 million in Q4 2021.
  • Average Operating Leases over 5 years is $143.4 million, with a median of $135.3 million recorded in 2024.
  • Peak YoY movement for Operating Leases: soared 59.71% in 2021, then fell 17.42% in 2024.
  • A 5-year view of Operating Leases shows it stood at $118.9 million in 2021, then surged by 45.75% to $173.3 million in 2022, then decreased by 5.5% to $163.8 million in 2023, then dropped by 17.42% to $135.3 million in 2024, then fell by 7.05% to $125.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Operating Leases are $125.7 million (Q4 2025), $135.3 million (Q4 2024), and $163.8 million (Q4 2023).